- Home
- TARS vs ACLS Comparison
TARS vs ACLS Comparison
Compare TARS & ACLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- ACLS
- Stock Information
- Founded
- TARS 2016
- ACLS 1995
- Country
- TARS United States
- ACLS United States
- Employees
- TARS N/A
- ACLS N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- ACLS Industrial Machinery/Components
- Sector
- TARS Health Care
- ACLS Technology
- Exchange
- TARS Nasdaq
- ACLS Nasdaq
- Market Cap
- TARS 2.0B
- ACLS 2.2B
- IPO Year
- TARS 2020
- ACLS 2000
- Fundamental
- Price
- TARS $47.84
- ACLS $63.11
- Analyst Decision
- TARS Strong Buy
- ACLS Buy
- Analyst Count
- TARS 6
- ACLS 7
- Target Price
- TARS $56.00
- ACLS $156.00
- AVG Volume (30 Days)
- TARS 460.8K
- ACLS 766.6K
- Earning Date
- TARS 02-25-2025
- ACLS 02-10-2025
- Dividend Yield
- TARS N/A
- ACLS N/A
- EPS Growth
- TARS N/A
- ACLS N/A
- EPS
- TARS N/A
- ACLS 6.15
- Revenue
- TARS $129,621,000.00
- ACLS $1,017,865,000.00
- Revenue This Year
- TARS $921.89
- ACLS N/A
- Revenue Next Year
- TARS $85.83
- ACLS $11.97
- P/E Ratio
- TARS N/A
- ACLS $10.26
- Revenue Growth
- TARS 801.96
- ACLS N/A
- 52 Week Low
- TARS $20.08
- ACLS $56.32
- 52 Week High
- TARS $57.28
- ACLS $158.61
- Technical
- Relative Strength Index (RSI)
- TARS 39.21
- ACLS 42.46
- Support Level
- TARS $49.86
- ACLS $59.78
- Resistance Level
- TARS $53.22
- ACLS $65.59
- Average True Range (ATR)
- TARS 2.44
- ACLS 2.90
- MACD
- TARS -0.56
- ACLS 0.13
- Stochastic Oscillator
- TARS 7.09
- ACLS 59.51
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provide aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services and customer training. Geographically, the group has a business presence in North America, Asia Pacific and Europe, of which key revenue is derived from the Asia Pacific.